Navigation Links
New Approach to Early Detection of Ovarian Cancer

Despite advances in surgery and chemotherapy, ovarian cancer is still the most lethal form of gynecologic cancer and the fourth leading cause of cancer death among women// in the United States; claiming 16,210 lives in 2005.

Survival rates for ovarian cancer have remained stubbornly low because symptoms are often vague and mimic other conditions, and the lack of a cost-effective, reliable test to diagnose this “silent killer” early, when it is most curable. A test is urgently needed that would rival the positive impact on survival that the Pap smear and mammography have had on cancers of the cervix and breast, respectively.

The statistics tell the story. Currently, three of every four women have advanced stage ovarian cancer when they are diagnosed, and only 25 percent of these women survive for five years. In contrast, the one woman in four diagnosed with early stage disease has a five-year survival rate exceeding 90 percent.

Now, innovative research at Roswell Park Cancer Institute and the University at Buffalo has produced compelling evidence that a simple blood test for early ovarian cancer screening might be developed sooner rather than later.

Scientists at these institutions have used sophisticated computer-modeling programs to interpret data from nuclear magnetic resonance (NMR) analyses of blood samples and produce cellular profiles that show the identities, structures and proportions of metabolites (metabonomics).

This NMR-based metabonomics approach has identified characteristics, known as biomarkers, in blood samples that can leave a “biomolecular signature” that distinguishes women with early stage ovarian cancer from healthy women. Scientists believe that these biomarkers could be developed into a screening test for ovarian cancer.

However, before this simple blood test can be developed, researchers will use the same approach to hone in on the specific metabolite (or metabolites) re sponsible for differences between healthy women and cancer patients, and make early diagnosis of ovarian cancer possible. These metabolites also could be targets for therapy.

Scientists believe that this NMR-based metabonomics approach will not only benefit thousands of women each year, but have practical implications in other types of cancer as well.

(Source: Newswis)
'"/>




Related medicine news :

1. New Dietary Approach To Manage Kidney Stones
2. Approaching through Telemedicine benefits patients
3. Gel Offers A More Targeted Approach
4. New Cost Effective Approach To Promote Sun Protection
5. Treatment Of Brain Aneurysms By A New Non-Surgical Approach
6. A New Approach In Treatment Neurogenic Detrusor Overactivity In Children
7. A New Diagnostic Approach To Pediatric Interstitial Lung Disease
8. Lazy Eye Can Be Effectively Treated By New Approach
9. Novel Approach to Identify Protein Links with Genetic Disorder
10. NHS To Be Reformed By Using A Hybrid Approach
11. Two-In One Approach To Prevent Incontinence After Prolapse Surgery
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/30/2016)... ... 30, 2016 , ... “Aging well is a challenge for all of us, but there are things we can ... Kohli . “Research is showing more and more that there are simple, yet important steps ... as we age.” Top priorities Dr. Kohli’s recommends for her patients include;, , ...
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... In an ... mother and divorcee, shares her enthusiasm for Botox and lip injections, which she underwent ... famous youth oriented Coachella Valley Music and Arts Festival. The article explains that Ms. ...
(Date:4/29/2016)... ... April 29, 2016 , ... Our bodies are bombarded daily ... confront and deal with these stressors is to adopt a more healthful diet, but ... you. Risa Groux, a certified Holistic Nutritionist and the creator of the Newport Beach ...
(Date:4/29/2016)... ... April 29, 2016 , ... The ... in repaying their loans, more information about their loan terms and accounts, and ... student loan debt, including federal and private loans, has reached $1.3 trillion, with ...
(Date:4/29/2016)... ... April 29, 2016 , ... Spine Team Texas, a comprehensive spine ... announce one of their physicians has been invited to be a featured speaker at ... Practice Review conference on April 30, 2016. , Dr. R. Scott McPherson, a ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)... 27, 2016 Global  urinalysis ... billion by 2022, according to a new report ... (Logo: http://photos.prnewswire.com/prnh/20150105/723757 ) , ... efficiency and accuracy delivered by the new generation ... novel urinalysis instruments and consumables. For instance, the ...
(Date:4/27/2016)... -- At the Sachs CEO forum in ... 2 clinical study of its lead drug candidate, STR001, ... (CI) surgery. This large, placebo-controlled, double-blind, phase 2 study ... and France . STR001 is ... of surgery. "Despite advances in cochlear implant technology, a ...
(Date:4/26/2016)... , April 26, 2016 Hill-Rom Holdings, Inc. ... a management presentation at the Deutsche Bank 41 st ... 2:50 p.m. EDT. You are invited to listen ... http://ir.hill-rom.com/events.cfm or access it directly at http://edge.media-server.com/m/p/mr4uxgas . ... hour after conclusion of the live event and accessible at ...
Breaking Medicine Technology: